Industrial LayoutYantai Dongcheng Pharmaceutical Group Co., Ltd. was established in 1998 and has obtained GMP certification from the National Medical Products Administration (NMPA) and ISO9001 certification from the Norwegian Classification Society (DNV). At present, the main products of active pharmaceutical ingredients include heparin series, chondroitin sulfate series, cytochrome C, collagen, etc.
As a leading enterprise in the heparin industry, Dongcheng has over 20 years of production experience and excellent production capacity, with a vertically integrated industrial chain structure that ensures product quality and traceability; And has multiple qualification certification backgrounds: the first in China to pass the MFDS GMP audit of the South Korean Food and Drug Administration, the first to pass the on-site inspection of PMDA GMP in Japan, possessing GMP certificates issued by BGV in Hamburg, Germany and NMPA in China, as well as the CEP certificate issued by EDQM in Europe; Assist in the revision of standards for heparin sodium raw materials in the Chinese Pharmacopoeia (2010/2015 edition), European Pharmacopoeia, and United States Pharmacopoeia.
The company's chondroitin sulfate production industry is leading, and it is the first domestic manufacturer to pass the USP certification in the United States; And obtained the CEP certificate issued by the EU EDQM, as well as the GMP certificate issued by BGV in Hamburg, Germany, MFDS in South Korea, ANVISA in Brazil, and CFDA in China. Given Dongcheng's technical authority in the domestic biochemical industry, the company has been invited to assist in formulating the quality standards for chondroitin sulfate sodium products in the Chinese Pharmacopoeia (2010/2015 edition). In 2016, we acquired Zhongtai Biological Products Co., Ltd., which holds the USP certification in the United States and the HACCP certificate issued by the Thai health authorities, further consolidating our position in the global chondroitin industry.
The company has a relatively complete sales network, exporting to more than 40 countries and regions around the world, with customers covering well-known pharmaceutical manufacturers and intermediaries worldwide. The company has established long-term stable and good cooperative relationships with multiple pharmaceutical and health product companies around the world; And actively cultivate and explore the domestic market.

